Cargando…

Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound

BACKGROUND: Hepatocellular carcinoma (HCC) accounts for 75 % of liver cancers and is the second most lethal cancer, associated with its multiple etiologies, poor prognosis and resistance to chemotherapy drugs. Chemotherapy treatment on HCC suffers low efficacy of drug uptake and can produce a range...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zheng, Lv, Guixiang, Li, Yongning, Li, Enze, Li, Haixia, Zhou, Qi, Yang, Bin, Cao, Wenwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840943/
https://www.ncbi.nlm.nih.gov/pubmed/27102814
http://dx.doi.org/10.1186/s13046-016-0349-4
_version_ 1782428324731027456
author Hu, Zheng
Lv, Guixiang
Li, Yongning
Li, Enze
Li, Haixia
Zhou, Qi
Yang, Bin
Cao, Wenwu
author_facet Hu, Zheng
Lv, Guixiang
Li, Yongning
Li, Enze
Li, Haixia
Zhou, Qi
Yang, Bin
Cao, Wenwu
author_sort Hu, Zheng
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) accounts for 75 % of liver cancers and is the second most lethal cancer, associated with its multiple etiologies, poor prognosis and resistance to chemotherapy drugs. Chemotherapy treatment on HCC suffers low efficacy of drug uptake and can produce a range of side effects. Here we report an investigation on the effect of a combined treatment on human hepatocellular carcinoma BEL-7402 cells using low-intensity ultrasound (US) and 5-fluorouracil (5-FU). METHODS: The uptake of 5-FU was measured by the high-performance liquid chromatography (HPLC). DNA damage was detected by the comet assay. MTT assay was used to examine cell viability. Intracellular reactive oxygen species (ROS) and mitochondrial membrane potential (Δψm) were respectively detected by the fluorescent probes DCFH-DA or JC-1. Endogenous apoptosis-associated proteins were analyzed by the western blot and immunohistochemistry. Histopathological changes were evaluated by the hematoxylin and eosin (H&E) staining. Cell apoptosis was evaluated by the TUNEL and flow cytometry assays. Cell proliferation was measured using the immunohistochemical staining of PCNA. RESULTS: Our results showed that low-intensity US (1.1 MHz, 1.0 W/cm(2), 10 % duty cycle) significantly enhanced the uptake of 5-FU, 5-FU-mediated DNA damage and reactive oxygen species (ROS) generation. The increased ROS production up-regulated the p53 protein level, which led to the up-regulation of Bax and down-regulation of Bcl-2. The enhancement of ROS generation and the activation of the apoptosis-associated proteins further triggered the collapse of mitochondrial membrane potential, released cytochrome c from mitochondria into cytosol and activated the mitochondria-caspase pathway, and cell apoptosis. Such enhanced effects could be partially blocked by the ROS scavenger N-acetylcysteine (NAC). Overall, low-intensity US combined with 5-FU led to an effective inhibition of tumor growth and prolonged overall survival of BEL-7402 HCC-bearing nude mice by more than 15 % compared with 5-FU treatment alone. CONCLUSIONS: Our results showed that low-intensity ultrasound combined with 5-FU produced much enhanced synergistic anti-tumor effects via enhanced ROS production in treating HCC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-016-0349-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4840943
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48409432016-04-23 Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound Hu, Zheng Lv, Guixiang Li, Yongning Li, Enze Li, Haixia Zhou, Qi Yang, Bin Cao, Wenwu J Exp Clin Cancer Res Research BACKGROUND: Hepatocellular carcinoma (HCC) accounts for 75 % of liver cancers and is the second most lethal cancer, associated with its multiple etiologies, poor prognosis and resistance to chemotherapy drugs. Chemotherapy treatment on HCC suffers low efficacy of drug uptake and can produce a range of side effects. Here we report an investigation on the effect of a combined treatment on human hepatocellular carcinoma BEL-7402 cells using low-intensity ultrasound (US) and 5-fluorouracil (5-FU). METHODS: The uptake of 5-FU was measured by the high-performance liquid chromatography (HPLC). DNA damage was detected by the comet assay. MTT assay was used to examine cell viability. Intracellular reactive oxygen species (ROS) and mitochondrial membrane potential (Δψm) were respectively detected by the fluorescent probes DCFH-DA or JC-1. Endogenous apoptosis-associated proteins were analyzed by the western blot and immunohistochemistry. Histopathological changes were evaluated by the hematoxylin and eosin (H&E) staining. Cell apoptosis was evaluated by the TUNEL and flow cytometry assays. Cell proliferation was measured using the immunohistochemical staining of PCNA. RESULTS: Our results showed that low-intensity US (1.1 MHz, 1.0 W/cm(2), 10 % duty cycle) significantly enhanced the uptake of 5-FU, 5-FU-mediated DNA damage and reactive oxygen species (ROS) generation. The increased ROS production up-regulated the p53 protein level, which led to the up-regulation of Bax and down-regulation of Bcl-2. The enhancement of ROS generation and the activation of the apoptosis-associated proteins further triggered the collapse of mitochondrial membrane potential, released cytochrome c from mitochondria into cytosol and activated the mitochondria-caspase pathway, and cell apoptosis. Such enhanced effects could be partially blocked by the ROS scavenger N-acetylcysteine (NAC). Overall, low-intensity US combined with 5-FU led to an effective inhibition of tumor growth and prolonged overall survival of BEL-7402 HCC-bearing nude mice by more than 15 % compared with 5-FU treatment alone. CONCLUSIONS: Our results showed that low-intensity ultrasound combined with 5-FU produced much enhanced synergistic anti-tumor effects via enhanced ROS production in treating HCC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-016-0349-4) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-22 /pmc/articles/PMC4840943/ /pubmed/27102814 http://dx.doi.org/10.1186/s13046-016-0349-4 Text en © Hu et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hu, Zheng
Lv, Guixiang
Li, Yongning
Li, Enze
Li, Haixia
Zhou, Qi
Yang, Bin
Cao, Wenwu
Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound
title Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound
title_full Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound
title_fullStr Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound
title_full_unstemmed Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound
title_short Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound
title_sort enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840943/
https://www.ncbi.nlm.nih.gov/pubmed/27102814
http://dx.doi.org/10.1186/s13046-016-0349-4
work_keys_str_mv AT huzheng enhancementofantitumoreffectsof5fluorouracilonhepatocellularcarcinomabylowintensityultrasound
AT lvguixiang enhancementofantitumoreffectsof5fluorouracilonhepatocellularcarcinomabylowintensityultrasound
AT liyongning enhancementofantitumoreffectsof5fluorouracilonhepatocellularcarcinomabylowintensityultrasound
AT lienze enhancementofantitumoreffectsof5fluorouracilonhepatocellularcarcinomabylowintensityultrasound
AT lihaixia enhancementofantitumoreffectsof5fluorouracilonhepatocellularcarcinomabylowintensityultrasound
AT zhouqi enhancementofantitumoreffectsof5fluorouracilonhepatocellularcarcinomabylowintensityultrasound
AT yangbin enhancementofantitumoreffectsof5fluorouracilonhepatocellularcarcinomabylowintensityultrasound
AT caowenwu enhancementofantitumoreffectsof5fluorouracilonhepatocellularcarcinomabylowintensityultrasound